ehealth radio network
Taking Control of Germs in the Palm of Your Hand with UVCeed

Taking Control of Germs in the Palm of Your Hand with UVCeed

January 21, 2022

 

61b959137b525c14c09c021a_1516954488432.jpeg

 

Dr. Peter Bonutti, M.D., the Co-founder & CEO of UVCeed, a smart UVC disinfection system to help limit the spread of infections, particularly COVID-19 joins eHealth Radio and the COVID-19 Information and Disinfection Channels. Dr. Bonutti is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience.


Listen to interview with host Eric Michaels and guest Dr. Peter Bonutti discuss the following:

  1. As an MD why did you see the need to create a UV disinfection solution for consumers?
  2. What is the problem you are solving? What is the science behind UVCeed? How does it work?
  3. What are some of the most common uses for the product?
  4. UVCeed eliminates 99.9 of the germs including Covid-19. Does this eliminate the need for face masks and sanitizers now?
  5. Where can our audience get the app and the device today?

Dr. Peter Bonutti, M.D. is co-founder & CEO of UVCeed. He created the smart UVC disinfection system to help limit the spread of infections, particularly COVID-19.

Dr. Bonutti is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience. He is the founder of Bonutti Research, a medical device incubator that has developed products and technology used around the world, including UVCeed, and maintains his clinical and surgical practice, focusing on adult knee and hip arthroplasty and integration of robotics into surgical procedures.

Dr. Bonutti is a pioneer in Minimally Invasive Surgery, has over 500 patents and applications, more than 700 licenses and multiple FDA-approved products to date. Major corporations leveraging his technology include Hitachi, Medtronic, Kyphon, Covidien, US Surgical, Biomet, Arthrocare, Synthes, Zimmer/Biomet and Stryker. He is a prolific speaker, lecturing internationally, and has trained over 100 surgeons on his surgical techniques.

In his career, Dr. Bonutti has received more than a dozen industry honors and awards for his achievements. Dr. Bonutti earned his medical degree at University of Cincinnati College of Medicine and completed his Orthopaedic Surgery Residency at Cleveland Clinic Foundation with international fellowships in Canada, Australia, and Austria.

 

UVCEED_LOGO.png

 

Website: https://uvceed.com 

Social Media Links:
Instagram: https://instagram.com/uvceedsanitizer  
Linkedin: https://linkedin.com/company/bonutti-technologies/about 

 

Dr. Martin M. Grajower, discusses innovations to help both physicians and patients fight the silent epidemic of fatty liver disease

Dr. Martin M. Grajower, discusses innovations to help both physicians and patients fight the silent epidemic of fatty liver disease

January 6, 2022

 

MartinGrajower_2.jpeg

 

Dr. Martin M. Grajower, M.D., FACP, FACE, a Clinical Professor of Medicine, Division of Endocrinology, at Albert Einstein College of Medicine, Bronx, New York, joins eHealth Radio and the Health News and Technology Channels to discuss innovations to help both physicians and patients fight the silent epidemic of fatty liver disease.


Listen to interview with host Eric Michaels and guest Dr. Martin M. Grajower discuss the following:

  1. What are the main risk factors for nonalcoholic fatty liver disease (NAFLD)?
  2. Can you explain the role that obesity plays in connection with NAFLD and diabetes?
  3. What are the health risks associated with having NAFLD?
  4. At what point should endocrinologists screen for NAFLD in patients with Type 2 diabetes?
  5. Can you provide an example of how endocrinologists can help their patients who are at risk for liver disease?

Martin Grajower MD FACP FACE is an endocrinologist in the Bronx, New York, and is affiliated with Montefiore Medical Center and Columbia University Hospital of Physicians and Surgeons. He received his medical degree from Albert Einstein College of Medicine and has been in private practice for over 40 years. He holds the title of Clinical Professor of Medicine, Division of Endocrinology, at Albert Einstein College of Medicine.

 

About Echosens

Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.

 

logo_echosens_gradient6xp78.png

 

Website: https://echosens.com

Social Media Links:
Facebook: facebook.com/fibroscan.echosens 
Linkedin: linkedin.com/company/echosens 
Youtube: youtube.com/user/EchosensTV
Twitter: twitter.com/Echosens

Podbean App

Play this podcast on Podbean App